Additionally, hyptolide treatment increased ABCG2 expression and reduced P-gp expression in cisplatin-resistant CP1#1 and CP1#2 cells, which is a possible therapeutic mechanism for overcoming drug-resistant cancer cells (Fig. 2). The gene discussed is ABCG2; the disease is cancer.